TW200724140A - Hydantoin compounds - Google Patents

Hydantoin compounds

Info

Publication number
TW200724140A
TW200724140A TW095118533A TW95118533A TW200724140A TW 200724140 A TW200724140 A TW 200724140A TW 095118533 A TW095118533 A TW 095118533A TW 95118533 A TW95118533 A TW 95118533A TW 200724140 A TW200724140 A TW 200724140A
Authority
TW
Taiwan
Prior art keywords
hydantoin compounds
hydantoin
compounds
treating
relates
Prior art date
Application number
TW095118533A
Other languages
English (en)
Inventor
Eric Carlson
Qian Chen
Heather Davis
Brian M Gallagher Jr
Shawn Schiller
Christina Shaffer
Mark Spyvee
Nancy Wong
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of TW200724140A publication Critical patent/TW200724140A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
TW095118533A 2005-05-27 2006-05-25 Hydantoin compounds TW200724140A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68559405P 2005-05-27 2005-05-27

Publications (1)

Publication Number Publication Date
TW200724140A true TW200724140A (en) 2007-07-01

Family

ID=37189015

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095118533A TW200724140A (en) 2005-05-27 2006-05-25 Hydantoin compounds

Country Status (15)

Country Link
US (2) US7666875B2 (zh)
EP (2) EP2336131A1 (zh)
JP (1) JP2008542304A (zh)
KR (1) KR20080013931A (zh)
CN (1) CN101263141A (zh)
AU (1) AU2006251947A1 (zh)
BR (1) BRPI0609895A2 (zh)
CA (1) CA2609270A1 (zh)
DE (1) DE06771541T1 (zh)
IL (1) IL187279A0 (zh)
MX (1) MX2007014888A (zh)
NO (1) NO20076515L (zh)
RU (1) RU2007149327A (zh)
TW (1) TW200724140A (zh)
WO (1) WO2006128143A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds
WO2007139948A2 (en) * 2006-05-26 2007-12-06 Eisai R & D Management Co., Ltd Imidazoazepinone compounds
ATE474574T1 (de) 2006-05-26 2010-08-15 Eisai R&D Man Co Ltd Imidazoazephinonverbindungen
KR20090029703A (ko) * 2006-05-26 2009-03-23 에자이 알앤드디 매니지먼트 가부시키가이샤 이미다조아제피논 화합물
WO2008030412A2 (en) * 2006-09-07 2008-03-13 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
AU2007360955A1 (en) * 2007-11-15 2009-05-22 Eisai R & D Management Co., Ltd. Enantiomerically enriched imidazoazepinone compounds
EP2217242A1 (en) * 2007-11-15 2010-08-18 Eisai R&D Management Co., Ltd. Methods of use
EP2211616A4 (en) * 2007-11-26 2011-07-13 Eisai R&D Man Co Ltd PROCESS FOR PREPARING IMIDAZOAZEPINONE COMPOUNDS
ES2879351T3 (es) 2016-02-25 2021-11-22 Asceneuron Sa Sales de derivados de piperazina obtenidas por adición de ácidos
KR20180132629A (ko) 2016-02-25 2018-12-12 아셰뉴론 에스아 글리코시다제 저해제
US11795165B2 (en) 2018-08-22 2023-10-24 Asceneuron Sa Tetrahydro-benzoazepine glycosidase inhibitors
WO2020039029A1 (en) * 2018-08-22 2020-02-27 Asceneuron S. A. Spiro compounds as glycosidase inhibitors
WO2024092040A1 (en) * 2022-10-26 2024-05-02 Protego Biopharma, Inc. Spirocycle containing bicyclic heteroaryl compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US685594A (en) 1901-04-19 1901-10-29 Frank A Franklin Pulp-washing machine.
US7498323B2 (en) * 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
CA2579609A1 (en) * 2003-09-10 2005-03-17 Virochem Pharma Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
WO2006000096A1 (en) * 2004-06-25 2006-01-05 Virochem Pharma Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds

Also Published As

Publication number Publication date
NO20076515L (no) 2007-12-19
AU2006251947A1 (en) 2006-11-30
MX2007014888A (es) 2008-02-19
WO2006128143A3 (en) 2007-03-29
US7666875B2 (en) 2010-02-23
KR20080013931A (ko) 2008-02-13
BRPI0609895A2 (pt) 2011-10-11
CN101263141A (zh) 2008-09-10
IL187279A0 (en) 2008-02-09
RU2007149327A (ru) 2009-07-10
WO2006128143A2 (en) 2006-11-30
US20060270696A1 (en) 2006-11-30
EP1888583A2 (en) 2008-02-20
EP2336131A1 (en) 2011-06-22
JP2008542304A (ja) 2008-11-27
DE06771541T1 (de) 2008-09-11
US20100113446A1 (en) 2010-05-06
CA2609270A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
TW200724140A (en) Hydantoin compounds
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
IL197080A0 (en) Pyrimidone compounds as gsk-3 inhibitors
WO2007079214A3 (en) Prokineticin 2 receptor antagonists
EA201070238A1 (ru) Соединения пиримидина
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
MX2009005712A (es) Antagonistas de receptor de orexina de diazepam sustituido.
DE602007008434D1 (de) Rezeptoren
MX2009006339A (es) Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide.
JO2355B1 (en) Hereditary calcitonin polypeptide receptor antagonists
TW200640924A (en) VEGF-R2 inhibitors and methods
TW200630096A (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
PL1910338T3 (pl) Związki heterotetracykliczne jako mimetyki TPO
EP1861399A4 (en) CGRP RECEPTOR ANTAGONISTS
GB0510143D0 (en) Novel compounds A1
WO2009016253A3 (en) Cyanomethyl substituted n-acyl tryptamines
EA201070423A1 (ru) Диарильные соединения оксадиазолов
WO2003105840A3 (en) SPHINGOSINE KINASE INHIBITORS
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
UA100974C2 (ru) Соединения замещенных диазепанов как антагонисты орексиновых рецепторов
MX2008002166A (es) Compuestos y composiciones como mimeticos de trombopoietina (tpo).
RS20080246A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
JO2747B1 (en) Vehicles
IN2015DN03331A (zh)